BIOA
COM:BIOAGELABS
BioAge Labs
- Stock
Last Close
19.14
22/11 21:00
Market Cap
686.14M
Beta: -
Volume Today
157.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | ||
|---|---|---|---|---|---|---|
average inventory | 2.11M - | 1.78M 15.80% | 3.12M 75.92% | 4.66M 49.21% | ||
average payables | 506.48K - | 8.41M 1,560.25% | 10.93M 29.96% | 6.09M 44.29% | ||
average receivables | 615.92K - | 727.74K 18.16% | 982.78K 35.05% | 2.93M 197.71% | ||
book value per share | 4.17 - | 2.87 31.07% | 1.89 34.17% | 1.69 10.59% | 0.52 69.20% | |
capex per share | -0.82 - | |||||
capex to depreciation | -7.50 - | |||||
capex to operating cash flow | 0.46 - | |||||
capex to revenue | -4.80 - | |||||
cash per share | 5.37 - | 2.55 52.52% | 0.28 88.84% | 0.56 98.06% | 0.11 80.41% | |
days of inventory on hand | 327.86 - | 108.82 66.81% | 244.36 124.56% | 120.12 50.84% | 78.86 34.34% | |
days payables outstanding | 4.00 - | 59.39 1,383.42% | 2.21K 3,624.31% | 160.83 92.73% | 100.61 37.44% | |
days sales outstanding | 103.39 - | 112.80 9.09% | 164.46 45.80% | 43.55 73.52% | 118.83 172.88% | |
debt to assets | 0.43 - | 0.62 44.74% | 0.68 8.58% | 0.70 3.46% | 0.69 1.97% | |
debt to equity | 0.75 - | 1.65 118.56% | 2.09 26.49% | 2.33 11.51% | 2.18 6.27% | |
dividend yield | ||||||
earnings yield | ||||||
free cash flow per share | -2.59 - | -1.12 56.62% | -1.31 17.16% | -1.31 0.15% | -0.71 45.88% | |
free cash flow yield | ||||||
graham net net | 2.34 - | -2.13 191.10% | -3.60 69.02% | -3.27 9.16% | -0.88 73.04% | |
graham number | 14.14 - | 12.25 13.38% | 8.04 34.33% | 5.46 32.07% | 5.24 4.14% | |
income quality | 0.83 - | 0.48 41.63% | 0.86 78.83% | 1.67 93.47% | 0.30 81.86% | |
intangibles to total assets | 0.04 - | 0.03 23.52% | 0.05 49.92% | 0.04 14.17% | 0.06 38.71% | |
interest coverage | 5.54 - | |||||
interest debt per share | 1.43 - | 1.88 31.46% | 1.64 12.96% | 1.83 11.57% | 0.90 50.88% | |
inventory turnover | 1.11 - | 3.35 201.30% | 1.49 55.47% | 3.04 103.44% | 4.63 52.31% | |
invested capital | 0.46 - | 0.65 43.03% | 0.86 32.21% | 1.08 24.79% | 1.72 59.50% | |
net current asset value | 45.89M - | -37.82M 182.41% | -85.89M 127.10% | -81.42M 5.20% | -32.41M 60.19% | |
net debt to ebitda | 1.39 - | 0.30 78.55% | -1.00 435.84% | -2.72 171.77% | -0.37 86.34% | |
net income per share | -2.13 - | -2.32 8.85% | -1.52 34.49% | -0.78 48.39% | -2.34 198.39% | |
operating cash flow per share | -1.77 - | -1.12 36.46% | -1.31 17.16% | -1.31 0.15% | -0.71 45.88% | |
payables turnover | 91.16 - | 6.15 93.26% | 0.17 97.31% | 2.27 1,275.40% | 3.63 59.85% | |
receivables turnover | 3.53 - | 3.24 8.34% | 2.22 31.41% | 8.38 277.67% | 3.07 63.35% | |
research and ddevelopement to revenue | 6.22 - | 9.82 57.89% | 9.34 4.91% | 0.87 90.69% | 0.37 57.93% | |
return on tangible assets | -0.30 - | -0.31 3.50% | -0.27 13.11% | -0.15 46.83% | -1.50 930.83% | |
revenue per share | 0.17 - | 0.08 54.90% | 0.09 15.00% | 0.29 225.53% | 0.36 23.44% | |
roe | -0.51 - | -0.81 57.92% | -0.80 0.48% | -0.46 42.28% | -4.49 868.93% | |
roic | 0.77 - | -0.71 192.34% | -0.34 52.39% | -0.24 29.08% | -2.04 744.03% | |
sales general and administrative to revenue | 1.89 - | 4.00 112.11% | 3.04 24.13% | 0.79 73.94% | 0.70 11.91% | |
shareholders equity per share | 4.17 - | 2.87 31.07% | 1.89 34.17% | 1.69 10.59% | 0.52 69.20% | |
stock based compensation to revenue | 2.53 - | 4.50 78.31% | 2.21 51.02% | 0.43 80.38% | 0.35 19.91% | |
tangible asset value | 60.16M - | 52.57M 12.61% | 39.38M 25.10% | 41.74M 6.00% | 17.82M 57.31% | |
tangible book value per share | 3.86 - | 2.63 31.93% | 1.61 38.80% | 1.46 9.41% | 0.42 70.83% | |
working capital | 77.15M - | 34.19M 55.68% | -18.84M 155.09% | -13.88M 26.30% | 3.95M 128.47% |
All numbers in (except ratios and percentages)